TruCentive argues that flexible payment options can help research teams address practical barriers faced by participants. In a January 2025 article, the company connects that recommendation with the broader discussion of representation in clinical studies.

The article discusses the FDA’s June 2024 draft guidance on diversity action plans and an AMA policy adopted that month concerning inclusion in research. Those historical initiatives provide context for TruCentive’s commentary; the payment recommendations are the company’s own.

TruCentive highlights challenges such as limited access to conventional banking, the need for prompt reimbursement of travel or childcare costs, and preferences for particular payment methods.

Its proposed options include digital wallets, direct payments and locally relevant gift cards. The company recommends matching compensation delivery to the study population rather than assuming one method is equally accessible to every participant.

The article presents payment flexibility as one operational consideration within efforts to broaden participation. It argues that a usable and timely compensation process can support trust and engagement alongside the study’s recruitment and inclusion practices.